Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
French car maker Peugeot, rated on the lowest rung of investment grade, amassed €2.3bn of demand for a bond issue on Thursday, enabling it to raise €1bn, after crossover credit Nokia’s success selling debt earlier in the week made it clear that there is demand for issuers with trickier stories. -
Yihua Enterprise Group Co has defaulted on a Rmb1bn ($141m) domestic bond. It blamed the missed interest payment on the Covid-19 pandemic, but its financial health has been in question since last year.
-
GlobalCapital and Standard Chartered hosted a virtual roundtable in mid-April to discuss the changes China's high yield issuers have faced in 2020 — and the challenges they will have to contend with for the rest of the year due to the Covid-19 pandemic.
-
Chinese conglomerate HNA Group has missed yet another payment, this time of $750m, on a loan it raised in 2016 to acquire Ingram Micro, a US information technology and products distributor.
-
Chile priced the tightest EM sovereign bond in the Covid-19 era on Tuesday, selling a dollar deal flat or inside its curve and tight to where neighbouring rival Peru had issued last month.
-
Europe’s SMEs are in trouble. The coronavirus pandemic has zeroed revenues and threatens their very existence. They last faced a big threat in the 2008 crisis when bank lending dried up and a recession took hold. Back then, securitization took a lot of the blame as the cause, but this time it offers a route to rescue.
